Trials / Completed
CompletedNCT04166760
Metabolic Effects of Whey Compounds in Patients With Diabetes Mellitus Type 2.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of our study is to investigate the metabolic effects of a i) ordinary whey protein (WHE) and ii) a specific whey protein fraction (speWHE) when the interventions are ingested by patients with type 2 diabetes 30 minutes prior to an oral glucose tolerance test (OGTT). We will also investigate the glucose response when the patients ingest the interventions at home in their own environment 30 minutes before breakfast and dinner (2days) and also monitor glucose levels without interventions (2 days).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | speWHE | 25 gram of a specific whey fraction (confidential) |
| DIETARY_SUPPLEMENT | WHE | 25 gram protein of a regular whey compound |
Timeline
- Start date
- 2020-01-06
- Primary completion
- 2020-06-17
- Completion
- 2020-06-24
- First posted
- 2019-11-18
- Last updated
- 2020-11-06
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04166760. Inclusion in this directory is not an endorsement.